Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 204

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 204
---
 be regarded as independent if he or she:

| SANOFIFORM 20-F2024 | 99 |

| PART I                                             |
| ITEM 6. Directors, Senior Management and Employees |

• is not (and has not been during the past five years): – an employee or executive officer of the Company, – an employee, executive officer or director of an entity consolidated by the Company, or – an employee, executive officer or director of the Company’s parent, or of an entity consolidated by that parent (criterion 1); • is not an executive officer of an entity in which (i) the Company directly or indirectly holds a directorship or (ii) an employee of the Company is designated as a director or (iii) an executive officer of the Company (currently, or who has held office within the past five years) holds a directorship (criterion 2); • is not a customer, supplier, investment banker or corporate banker that is material to the Company or its group, or for whom the Company or its group represents a significant proportion of its business (criterion 3); • has no close family ties with a corporate officer of the Company (criterion 4); • has not acted as an auditor for the Company over the course of the past five years (criterion 5); • has not been a director of the Company for more than 12 years (criterion 6); • does not receive variable compensation in cash or in the form of shares or any compensation linked to the performance of the Company or its group (criterion 7); or • does not represent a shareholder that has a significant or controlling interest in the Company (criterion 8). The influence of other factors such as the ability to understand challenges and risks, and the courage to express ideas and form a judgment, is also evaluated before it is decided whether a director can be regarded as independent. In accordance with our Board Charter and pursuant to the AFEP-MEDEF Code, the Board of Directors’ meeting of February 12, 2025 discussed the independence of the current directors. Of the 17 directors in office on that date, 12 were deemed to be independent directors by reference to the independence criteria used by the Board of Directors pursuant to the AFEP- MEDEF Code: Frédéric Oudéa, Clotilde Delbos, Rachel Duan, Carole Ferrand, Lise Kingo, Jean-Paul Kress, Patrick Kron, Fabienne Lecorvaisier, Anne-F